Company Filing History:
Years Active: 2020
Title: Innovations of Xiaolu Han in Tumor-Specific Activation
Introduction
Xiaolu Han is an accomplished inventor based in Los Angeles, CA. She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative therapies for cancer treatment. Her work focuses on enhancing the effectiveness of chimeric antigen receptor T cells.
Latest Patents
Xiaolu Han holds a patent for her invention titled "Masking chimeric antigen receptor T cells for tumor-specific activation." This invention is directed to a masked chimeric antigen receptor, which comprises several key components: (a) a masking peptide; (b) one or more antigen-specific targeting domains; (c) an extracellular spacer domain; (d) a transmembrane domain; (e) at least one co-stimulatory domain; and (f) an intracellular signaling domain. The masked chimeric antigen receptors (mCARs) are activated upon cleavage of the masking peptide, allowing for targeted tumor-specific activation.
Career Highlights
Xiaolu Han is affiliated with the University of Southern California, where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve cancer therapies and patient outcomes.
Collaborations
Xiaolu collaborates with her coworker, Paul Bryson, who contributes to her research efforts. Together, they work on developing cutting-edge solutions in the field of cancer treatment.
Conclusion
Xiaolu Han's innovative work in the area of chimeric antigen receptor T cells represents a significant advancement in cancer therapy. Her contributions are paving the way for more effective treatments and improved patient care.